Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Heart Foundation Health Promotion Research Group, based in the Nuffield Department of Population Health, has been officially designated as a World Health Organization (WHO) Collaborating Centre.

The new centre will be known as the British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention. The launch of this centre will be held on the Monday the 28th of April from 10.00 am to 12.00 at the Richard Doll Building, Old Road Campus in Oxford.

The overall aim of the centre is to carry out research of the highest methodological quality that has the greatest possible influence on public health policy and practice, as it relates to the primary prevention of non-communicable disease (NCD).

The centre has five main research themes. They are:

  • Diet and nutrition
  • Physical activity
  • Obesity
  • Environmental sustainability
  • Cardiovascular disease epidemiology

As a WHO Collaborating Centre it will be:

  • Working with WHO in capacity building for population level approaches for NCD prevention
  • Contributing to WHO's work in the development of guidelines/manuals on population level NCD prevention.
  • Assisting WHO to develop methods for evaluating population level NCD prevention programmes including training programmes.
  • Providing WHO with statistical analysis and systematic reviews related to population level NCD prevention.

The United Nations meeting of the on the prevention and control of NCDs in September 2011 has resulted in a greater focus on population approaches to prevent NCDs, such as cardiovascular disease, cancer, diabetes and chronic respiratory disease.

Many countries are now considering and implementing population approaches to NCD prevention which include measures such as taxes on tobacco, alcohol and unhealthy foods, , bans on the advertising  of such products, providing better information about unhealthy products, and the provision of better facilities for active travel and recreation involving physical activity.

Evidence on the effectiveness of population approaches to NCD prevention is vitally important to make inform governments and other policy makers concerned about the rising burden of NCDs. This new centre will play a leading role in providing such evidence and help to build the capacity locally and internationally for population approaches for NCD prevention., 

For enquiries relating to the WHO Collaborating Centre’s activities please contact:

Dr Mike Rayner (mike.rayner@dph.ox.ac.uk) or Dr Kremlin Wickramasinghe (kremlin.wickramasinghe@dph.ox.ac.uk)

Similar stories

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.